SCHEMBL24873174

SCHEMBL24873174

CC(C)CCNC(=O)C(C)(C)CC(C)(C)C(=O)C(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 4/20 0.37
RNPEP Q9H4A4 3/20 0.37
DNPEP Q9ULA0 3/20 0.37
SMN1; SMN2 Q16637 5/20 0.35
RAB9A P51151 3/20 0.35
GAA P10253 1/20 0.35
NPC1 O15118 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CNR1 P21554 2/20 0.33
CNR2 P34972 1/20 0.33
KCNA5 P22460 1/20 0.32
POLB P06746 1/20 0.32
CYP2C19 P33261 1/20 0.32
LMNA P02545 2/20 0.32
PKM P14618 1/20 0.32
CYP1A2 P05177 1/20 0.32
MMP2 P08253 1/20 0.31
MMP8 P22894 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21696331 0.84 RAB9A (0.38) ANPEPRNPEPDNPEPSMN1; SMN2RAB9A
SCHEMBL21763558 0.84 ANPEP (0.40) ANPEPRNPEPDNPEPSMN1; SMN2RAB9A
SCHEMBL23734275 0.78 ANPEP (0.41) ANPEPRNPEPDNPEPSMN1; SMN2RAB9A
SCHEMBL23299774 0.77 CYP1A2 (0.33) CYP1A2
SCHEMBL18893563 0.77 CYP1A2 (0.39) CYP1A2
SCHEMBL22385106 0.76 CYP1A2 (0.36) CYP1A2
SCHEMBL12015001 0.75 ANPEP (0.44) ANPEPRNPEPDNPEPSMN1; SMN2RAB9A
SCHEMBL24913301 0.75 CNR1 (0.40) ANPEPRNPEPDNPEPSMN1; SMN2RAB9A
SCHEMBL21030119 0.74 CYP1A2 (0.35) CYP1A2MMP2MMP8
SCHEMBL18287157 0.72 ANPEP (0.42) ANPEPRNPEPDNPEPSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023281485-A1 MODIFIED IL-2 POLYPEPTIDES FOR TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES BRIGHT PEAK THERAPEUTICS AG (CH) 2023-01-12 WO disclosed